• レポートコード:QYR2104Z0352 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、95ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥553,800 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥830,700 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、強直性脊椎炎治療薬のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(シムジア、エンブレル、ヒュミラ、レミケード、シンポニー、その他)、用途別市場規模(病院、クリニック)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・強直性脊椎炎治療薬の市場動向 ・企業の競争状況、市場シェア ・強直性脊椎炎治療薬の種類別市場規模(シムジア、エンブレル、ヒュミラ、レミケード、シンポニー、その他) ・強直性脊椎炎治療薬の用途別市場規模(病院、クリニック) ・強直性脊椎炎治療薬の北米市場規模2016-2027(アメリカ、カナダ) ・強直性脊椎炎治療薬のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・強直性脊椎炎治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・強直性脊椎炎治療薬の中南米市場規模2016-2027(メキシコ、ブラジル) ・強直性脊椎炎治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Amgen、Wyeth、Takeda、Centocor、Schering-Plough、Mitsubishi Tanabe、Abbott、Eisai、Pfizer、Johnson & Johnson) ・結論 |
Market Analysis and Insights: Global Ankylosing Spondylitis Drug Market
The global Ankylosing Spondylitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ankylosing Spondylitis Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ankylosing Spondylitis Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ankylosing Spondylitis Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ankylosing Spondylitis Drug market.
Global Ankylosing Spondylitis Drug Scope and Market Size
Ankylosing Spondylitis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ankylosing Spondylitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cimzia
1.2.3 Enbrel
1.2.4 Humira
1.2.5 Remicade
1.2.6 Simponi
1.2.7 Others
1.3 Market by Application
1.3.1 Global Ankylosing Spondylitis Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ankylosing Spondylitis Drug Market Perspective (2016-2027)
2.2 Ankylosing Spondylitis Drug Growth Trends by Regions
2.2.1 Ankylosing Spondylitis Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ankylosing Spondylitis Drug Historic Market Share by Regions (2016-2021)
2.2.3 Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2022-2027)
2.3 Ankylosing Spondylitis Drug Industry Dynamic
2.3.1 Ankylosing Spondylitis Drug Market Trends
2.3.2 Ankylosing Spondylitis Drug Market Drivers
2.3.3 Ankylosing Spondylitis Drug Market Challenges
2.3.4 Ankylosing Spondylitis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ankylosing Spondylitis Drug Players by Revenue
3.1.1 Global Top Ankylosing Spondylitis Drug Players by Revenue (2016-2021)
3.1.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Players (2016-2021)
3.2 Global Ankylosing Spondylitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ankylosing Spondylitis Drug Revenue
3.4 Global Ankylosing Spondylitis Drug Market Concentration Ratio
3.4.1 Global Ankylosing Spondylitis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Drug Revenue in 2020
3.5 Ankylosing Spondylitis Drug Key Players Head office and Area Served
3.6 Key Players Ankylosing Spondylitis Drug Product Solution and Service
3.7 Date of Enter into Ankylosing Spondylitis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ankylosing Spondylitis Drug Breakdown Data by Type
4.1 Global Ankylosing Spondylitis Drug Historic Market Size by Type (2016-2021)
4.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2022-2027)
5 Ankylosing Spondylitis Drug Breakdown Data by Application
5.1 Global Ankylosing Spondylitis Drug Historic Market Size by Application (2016-2021)
5.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ankylosing Spondylitis Drug Market Size (2016-2027)
6.2 North America Ankylosing Spondylitis Drug Market Size by Type
6.2.1 North America Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
6.2.2 North America Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
6.2.3 North America Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
6.3 North America Ankylosing Spondylitis Drug Market Size by Application
6.3.1 North America Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
6.3.2 North America Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
6.3.3 North America Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
6.4 North America Ankylosing Spondylitis Drug Market Size by Country
6.4.1 North America Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
6.4.2 North America Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Ankylosing Spondylitis Drug Market Size (2016-2027)
7.2 Europe Ankylosing Spondylitis Drug Market Size by Type
7.2.1 Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
7.2.2 Europe Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
7.2.3 Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
7.3 Europe Ankylosing Spondylitis Drug Market Size by Application
7.3.1 Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
7.3.2 Europe Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
7.3.3 Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
7.4 Europe Ankylosing Spondylitis Drug Market Size by Country
7.4.1 Europe Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
7.4.2 Europe Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size (2016-2027)
8.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type
8.2.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application
8.3.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region
8.4.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ankylosing Spondylitis Drug Market Size (2016-2027)
9.2 Latin America Ankylosing Spondylitis Drug Market Size by Type
9.2.1 Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
9.2.2 Latin America Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
9.2.3 Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
9.3 Latin America Ankylosing Spondylitis Drug Market Size by Application
9.3.1 Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
9.3.2 Latin America Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
9.3.3 Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
9.4 Latin America Ankylosing Spondylitis Drug Market Size by Country
9.4.1 Latin America Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
9.4.2 Latin America Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size (2016-2027)
10.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type
10.2.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application
10.3.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country
10.4.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Ankylosing Spondylitis Drug Introduction
11.1.4 Amgen Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Wyeth
11.2.1 Wyeth Company Details
11.2.2 Wyeth Business Overview
11.2.3 Wyeth Ankylosing Spondylitis Drug Introduction
11.2.4 Wyeth Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.2.5 Wyeth Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Ankylosing Spondylitis Drug Introduction
11.3.4 Takeda Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Centocor
11.4.1 Centocor Company Details
11.4.2 Centocor Business Overview
11.4.3 Centocor Ankylosing Spondylitis Drug Introduction
11.4.4 Centocor Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.4.5 Centocor Recent Development
11.5 Schering-Plough
11.5.1 Schering-Plough Company Details
11.5.2 Schering-Plough Business Overview
11.5.3 Schering-Plough Ankylosing Spondylitis Drug Introduction
11.5.4 Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.5.5 Schering-Plough Recent Development
11.6 Mitsubishi Tanabe
11.6.1 Mitsubishi Tanabe Company Details
11.6.2 Mitsubishi Tanabe Business Overview
11.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Introduction
11.6.4 Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.6.5 Mitsubishi Tanabe Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Ankylosing Spondylitis Drug Introduction
11.7.4 Abbott Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Ankylosing Spondylitis Drug Introduction
11.8.4 Eisai Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.8.5 Eisai Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Ankylosing Spondylitis Drug Introduction
11.9.4 Pfizer Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Introduction
11.10.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cimzia
Table 3. Key Players of Enbrel
Table 4. Key Players of Humira
Table 5. Key Players of Remicade
Table 6. Key Players of Simponi
Table 7. Key Players of Others
Table 8. Global Ankylosing Spondylitis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Ankylosing Spondylitis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Ankylosing Spondylitis Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Ankylosing Spondylitis Drug Market Share by Regions (2016-2021)
Table 12. Global Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Ankylosing Spondylitis Drug Market Share by Regions (2022-2027)
Table 14. Ankylosing Spondylitis Drug Market Trends
Table 15. Ankylosing Spondylitis Drug Market Drivers
Table 16. Ankylosing Spondylitis Drug Market Challenges
Table 17. Ankylosing Spondylitis Drug Market Restraints
Table 18. Global Ankylosing Spondylitis Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Ankylosing Spondylitis Drug Market Share by Players (2016-2021)
Table 20. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Drug as of 2020)
Table 21. Ranking of Global Top Ankylosing Spondylitis Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Ankylosing Spondylitis Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Ankylosing Spondylitis Drug Product Solution and Service
Table 25. Date of Enter into Ankylosing Spondylitis Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Ankylosing Spondylitis Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. Amgen Company Details
Table 66. Amgen Business Overview
Table 67. Amgen Ankylosing Spondylitis Drug Product
Table 68. Amgen Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 69. Amgen Recent Development
Table 70. Wyeth Company Details
Table 71. Wyeth Business Overview
Table 72. Wyeth Ankylosing Spondylitis Drug Product
Table 73. Wyeth Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 74. Wyeth Recent Development
Table 75. Takeda Company Details
Table 76. Takeda Business Overview
Table 77. Takeda Ankylosing Spondylitis Drug Product
Table 78. Takeda Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 79. Takeda Recent Development
Table 80. Centocor Company Details
Table 81. Centocor Business Overview
Table 82. Centocor Ankylosing Spondylitis Drug Product
Table 83. Centocor Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 84. Centocor Recent Development
Table 85. Schering-Plough Company Details
Table 86. Schering-Plough Business Overview
Table 87. Schering-Plough Ankylosing Spondylitis Drug Product
Table 88. Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 89. Schering-Plough Recent Development
Table 90. Mitsubishi Tanabe Company Details
Table 91. Mitsubishi Tanabe Business Overview
Table 92. Mitsubishi Tanabe Ankylosing Spondylitis Drug Product
Table 93. Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 94. Mitsubishi Tanabe Recent Development
Table 95. Abbott Company Details
Table 96. Abbott Business Overview
Table 97. Abbott Ankylosing Spondylitis Drug Product
Table 98. Abbott Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 99. Abbott Recent Development
Table 100. Eisai Company Details
Table 101. Eisai Business Overview
Table 102. Eisai Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 103. Eisai Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Ankylosing Spondylitis Drug Product
Table 107. Pfizer Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Johnson & Johnson Company Details
Table 110. Johnson & Johnson Business Overview
Table 111. Johnson & Johnson Ankylosing Spondylitis Drug Product
Table 112. Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 113. Johnson & Johnson Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ankylosing Spondylitis Drug Market Share by Type: 2020 VS 2027
Figure 2. Cimzia Features
Figure 3. Enbrel Features
Figure 4. Humira Features
Figure 5. Remicade Features
Figure 6. Simponi Features
Figure 7. Others Features
Figure 8. Global Ankylosing Spondylitis Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Ankylosing Spondylitis Drug Report Years Considered
Figure 12. Global Ankylosing Spondylitis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Ankylosing Spondylitis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Ankylosing Spondylitis Drug Market Share by Regions: 2020 VS 2027
Figure 15. Global Ankylosing Spondylitis Drug Market Share by Regions (2022-2027)
Figure 16. Global Ankylosing Spondylitis Drug Market Share by Players in 2020
Figure 17. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Drug as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Drug Revenue in 2020
Figure 19. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2016-2021)
Figure 20. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2022-2027)
Figure 21. North America Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 23. North America Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 24. North America Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
Figure 25. United States Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 29. Europe Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 30. Europe Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
Figure 31. Germany Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Region (2016-2027)
Figure 41. China Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 49. Latin America Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 50. Latin America Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
Figure 51. Mexico Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
Figure 57. Turkey Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 61. Wyeth Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 63. Centocor Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 64. Schering-Plough Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 65. Mitsubishi Tanabe Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 66. Abbott Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 67. Eisai Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed